• Nuclear Medicine and Molecular Imaging
• /
• 제41권1호
• /
• pp.9-15
• /
• 2007

목적: 두부 외부에서 두뇌를 직접 자극하는 비침습적 두뇌 자극술인 경두개 자기자극(TMS, transcranial magnetic stimulation)은 특정 두뇌 부위를 자극하여 두뇌 활성을 증가 혹은 감소시킬 수 있다. 특히 반복 TMS(repetitive TMS, 이하 rTMS)는 우울증, 강박장애, 정신분열증 등 일부 신경 정신과적 질환의 새로운 치료법으로서의 가능성이 제시되면서 다양한 연구가 행해지고 있다. 이에 본 연구는 치료 저항성 우울증 환자를 대상으로 rTMS 치료 전후의 국소뇌혈류 변화를 알아보고자 하였다. 대상 및 방법: 1년 이상 적당한 항우울제 투여를 시도하였음에도 불구하고 치료에 반응하지 않았던 치료 저항성 우울증 환자 12명(남: 7, 녀: 5, 나이범위: $19{\sim}52$세, 평균나이: $29.3{\pm}9.3$세)을 대상으로 하여 3주간 15회의 rTMS(우측 전전두엽: 1Hz, 좌측 전전두엽: 20Hz) 치료 시행 전과 치료 후에 Tc-99m ECD SPECT를 얻었다. 치료 전과 후의 차이를 SPM2 소프트웨어를 이용하여 비교하였다.(t=3.14, uncorrected p<0.01, voxel=100) 결과: rTMS 치료 후에 좌측 측두엽 전내측부와 좌측 기저핵 그리고 양측 전전두엽 피질부위에 혈류가 유의하게 증가하였다. 또한 우측 전두엽과 좌측 후두엽에서는 혈류가 유의하게 감소하였다. 결론: 치료 저항성 우울증 환자의 rTMS 치료는 특정 부위 두뇌의 혈류 증가와 감소가 있음을 확인할 수 있었다. 치료 성과 및 개인 특성에 따른 차이에 대한 분석을 시행하고 보다 많은 수의 환자에서 자료가 확보된다면 rTMS 치료의 기전과 우울증의 병태생리를 규명하는데 rTMS-기능 뇌영상 연계 연구가 매우 유용할 것이다.인 PET 연구 절차를 고안하기 위해 고려해야 할 사항들에 대하여 논하였다.TEX>$29.9{\pm}1.8%$, DMF: $7.6{\pm}0.5%$이었다. MEK에서 얻은 $[^{11}C]1$의 비방사능은 98 ($GBq/{\mu}mol$)이다. 각 물질의 질량 분석은 1: m/z 257.3 (M+1), 2: 257.3 (M+1), 3: 271.3 (M+1)이었다. 각 생성물질의 표지효율은 MEK에서 $86.0{\pm}5.5%:5.0{\pm}3.4%:1.5{\pm}1.3%$ $([^{11}C]1:[^{11}C]2:[^{11}C]3)$, CHO에서 $59.7{\pm}2.4%:4.7{\pm}3.2%:1.3{\pm}0.5%$, DEK에서 $29.9{\pm}1.8%:2.0{\pm}0.7%:0.3{\pm}0.1%$, DMF에서 $7.6{\pm}0.5%:0.0%:0.0%$이다. 결론: $[^{11}C]1$은 4가지 반응용매 중 MEK 반응용매에서 가장 높은 표지효율을 나타냈다. 부산물인 $[^{11}C]3$은 고성능 액체 크로마토그래피의 자외선, 방사능 검출기와 질량 분석법을 통해 물질을 추정할 수 있었다.의 개선 효과가 있는 것으로 판단되며 지질과산화에 대해서 강한 억제 활성을 나타내는 것을 알 수 있었다. 이러한 결과로 복분자는 생활 습관병의 예방과 개선에 유효한 것으로 사료되었으며, 지질대사와 과산화지표의 검증을 통해 기능성 식품소재로 활용될 수 있음을 보여주었다.로서 역시 CTV 치료계획에서 적게 조사되었다(p=0.005). 기존의 ICRU 치료계획은 잔류종양의 크기가 작은 경우 불필요하게 정상조직에

• 우울조울병
• /
• 제16권3호
• /
• pp.140-151
• /
• 2018

Objectives : The purpose of this study was to examine effects of adjunctive aripiprazole versus bupropion, on depressive symptoms of female depression. Methods : Sixty six female patients with major depressive disorders were enrolled from a six-week, randomized prospective open-label multi-center study. Participants were randomized to receive aripiprazole (2.5-10 mg/day) or bupropion (150-300 mg/day). Montgomery Asberg Depression Rating Scale, 17-item Hamilton Depression Rating scale (HAM-D17), Iowa Fatigue Scale, Drug-Induced Extrapyramidal Symptoms Scale, Psychotropic-Related Sexual Dysfunction Questionnaire scores, and Clinical Global Impression-Severity (CGI-S) were obtained at baseline and after one, two, four, and six weeks. Changes on individual items of HAM-D17 were assessed as well as on composite scales (anxiety, insomnia and drive), and on four core subscales that capture core depression symptoms. Results : Overall, both treatments improved depressive symptoms, without causing serious adverse events. There were significant differences in the HAM-D17 total score (p=0.046) and CGI-S (p=0.004), between aripiprazole and bupropion augmentation, favoring aripiprazole over bupropion. Aripiprazole revealed significantly greater effect size in depressed mood (p=0.006), retardation (p=0.005), anxiety psychic (p=0.032), and general somatic symptom (p=0.01). Conclusion : While both treatments were effective, results of this study suggested that aripiprazole may be preferable, in treating general and core symptoms of female depression.

• 한국임상수의학회지
• /
• 제28권4호
• /
• pp.442-445
• /
• 2011

Macrocyclic lactone에 저항이 있는 Parascaris equorum은 몇몇 국가에서 보고되었다. 그랜트얼룩말(Equus burchelli bohmi)이 만성체중감소 및 심한 침울로 인하여 제주경마공원동물병원에 내원하였다. 임상검사에서 빈맥 및 탈수가 밝혀졌고 다음날 심한 복통을 앓고 난 후 폐사하였다. 내원하기 전에 얼룩말은 3개월 간격으로 3회에 걸쳐 ivermectin을 경구로 투여 받았고 첫 침울증상 30일 전에도 ivermectin으로 투여 받았다. 부검에서 위와 소장에 회충축적 및 장천공을 확인하였다. 저자들의 지식으로는 성숙한 얼룩말에서 ascarid impaction 및 장천공 예가 매우 드물다. 본 증례의 원인은 P. equorum이 ivermectin에 저항성이 있을 수 도 있다고 의심하고 있다.

• 한국세라믹학회지
• /
• 제32권3호
• /
• pp.385-393
• /
• 1995

Akali-resistant porous glass was prepared by phase separation in Na2O-B2O3-SiO2 system containing ZrO2 and MgO. ZrO2 was added for alkali-resistance and MgO for anti-cracking during leaching. Optimal content of ZrO2 for alkali-resistance was 7wt% and devitrification by heat treatment resulted from further addition. Pore size and pore volume were decreased and specific surface area was increased with ZrO2 addition due to depression in phase separation. Addition of 3mol% MgO to mother glass containing 7wt% ZrO2 was effective for anti-crack during leaching. In this case, with phase separation at 55$0^{\circ}C$ and 5$25^{\circ}C$ for 20 hrs. crack-free porous glasses could be prepared. The relation between pore size r and heat treatment time t at 55$0^{\circ}C$ was D=25.58＋18.16t. According to measurement of gas permeability, the mechanism of gas permeation was Knudsen flow. N2 and He permeability of porous glass which was prepared by heat treatment at 55$0^{\circ}C$ for 20 hrs. were 0.843$\times$10-7mol/$m^2$.s.Pa and 2.161$\times$10-7mol/$m^2$.s.Pa respectively.

• 한국초지조사료학회지
• /
• 제16권2호
• /
• pp.93-104
• /
• 1996

A field experiment was conducted in Chungju and Jungwon to evaluate growth characteristics, dry matter yield, protein yield and palatability of intercropping comparing with monocropping forage crops by the use of sorghum $\times$ sudangrass hybrid(S.S.H.), five forage soybeans and two forage cowpeas of superior to selected experiment of varieties. All eight treatment plots were replicated three times and cutting date were cut July 6 and September 9. 1. The mean leaf number of S.S.H. in intercropping T2 treatment showed high compared to T1 treatment in all treatment except for Hwangkeum treatment, but T3 treatment was lower than the other treatments. In the leaf number of soybean, Jangbaek treatment was the highest as 47 leaves per plant, cowpea treatments showed high above 50 leaves. The stem diameter of S.S.H. in Jangyeob treatment of T2 treatment was 9.6mm. In legume, cowpea of T3 treatment was high as ranged from 7.9mm to 8.2mm. In stem hardiness of S.S.H., TI treatment was the lower than the other treatments, while Jangbaek treatment of T2 treatment was the highest as $2.0kg/cm^2$. In legume crops, Jangbaek and Baekun treatment were the highest as $1.6kg/cm^2$, but T3 treatment was very low as $0.3~0.6kg/cm^2$. 2. In the mean leaf ratio of S.S.H., T1 treatment was higher than T2 and T3 treatment as 34.9%. In the legume crops, Togyu treatment was the highest as 40.9%. In the mean tiller number of S.S.H., T2 treatment showed high compared to TI treatment, but T3 treatment of was rather decrease than The tiller number of S.S.H. in Jangyeob treatment of T2 treatment was the highest as 4.6 per plant. The dead stubble of S.S.H. was high in order to T3>T1>T2 treatment>, T3 treatment was highly about 2 times compared to T2 treatment. 3. S.S.H. as T3 treatment was resistant to lodging, but T3 and T1 treatment showed highly lodging. In the legums, T3 treatment was resistant to lodging, but T2 treatment showed highly lodging. In the S.S.H. of T2 treatment, the leaf of summer depression was not occurrence, but T3 treatment was higher than the other treatments. 4. The palatability of domestic animals was high in order of T2>Tl>T3, especially Togyu treatment of T2 treatment was the highest at the holstein and deer, and Jangyeob treatment of T2 treatment was the highest in the Korean native cattle. But T3 treatment was lower than other treatments in the holstein and Korean native cattle. 5. Fresh yield of monocropping(T1) was the highest as 94, 650kg/ha, while dry matter yield in Jangyeob treatment of T2 treatment was the highest as 15, 575/ha But fresh yield and dry matter yield of T3 treatment were the lowest(P<0.05). 6. Protein yield in T2 treatment was high, especially Jangyeob treatment of T2 treatment was the highest as 1, 605.5 kg/ha T3 treatment was low in spite of high protein content, because dry matter yield was lower than the other treatments. In conclusion, among T1, T2 and T3 treatment, Jangyeob, Togyu and Baekun treatments of T2 treatment showed optimum varieties for intercropping with S.S.H., because they showed high Dry matter yield, protein yield and palatability.

• 대한수의학회지
• /
• 제45권4호
• /
• pp.563-568
• /
• 2005

The present study was conducted to investigate biochemical characteristics and antimicrobial susceptibility of Aeromonas hydrophilia isolated from Jackass penguins (Spheniscus demersus) of zoo and capelins (Mallotus villosus). Seven of Jackass penguins showed anorexia, depression with seriously greenish vomiting for a few days, but resulted in 4 deaths although extensive treatment was carried out by zoo veterinarians. From the 18 samples composed of organs or feces from dead or live Jackass penguins and capelins, 4 (22.2%) Aeromonas hydrophilia were isolated and Bacillus spp, Staphylococcus aureus, Staphylococcus auricularis, Staphylococcus cohnii and Enterobacter aminigenus were also identified. Antimicrobial susceptibility tests of Aeromonas hydrophilia showed that all isolates were susceptible to amikacin, gentamicin, kanamycin, norfloxacin and trimethoprim- sulfadimethoxazole. However, all isolates were resistant to the following antimicrobials; ampicillin, bacitracin, c ephalothin, cefazolin, noboviocin, penicillin and vancomycin.

• Journal of Korean Neurosurgical Society
• /
• 제62권3호
• /
• pp.344-352
• /
• 2019

Epilepsy is one of the major chronic neurological diseases affecting many patients. Resection surgery is the most effective therapy for medically intractable epilepsy, but it is not feasible in all patients. Vagus nerve stimulation (VNS) is an adjunctive neuromodulation therapy that was approved in 1997 for the alleviation of seizures; however, efforts to control epilepsy by stimulating the vagus nerve have been studied for over 100 years. Although its exact mechanism is still under investigation, VNS is thought to affect various brain areas. Hence, VNS has a wide indication for various intractable epileptic syndromes and epilepsy-related comorbidities. Moreover, recent studies have shown anti-inflammatory effects of VNS, and the indication is expanding beyond epilepsy to rheumatoid arthritis, chronic headaches, and depression. VNS yields a more than 50% reduction in seizures in approximately 60% of recipients, with an increase in reduction rates as the follow-up duration increases. The complication rate of VNS is 3-6%, and infection is the most important complication to consider. However, revision surgery was reported to be feasible and safe with appropriate measures. Recently, noninvasive VNS (nVNS) has been introduced, which can be performed transcutaneously without implantation surgery. Although more clinical trials are being conducted, nVNS can reduce the risk of infection and subsequent device failure. In conclusion, VNS has been demonstrated to be beneficial and effective in the treatment of epilepsy and various diseases, and more development is expected in the future.

• 생물정신의학
• /
• 제18권3호
• /
• pp.163-167
• /
• 2011

Complex regional pain syndrome (CRPS) is a disease that causes chronic spontaneous pain and hyperesthesia of one or more parts of legs and arms, which is accompanied with problems of the automatic nervous system or the motor nervous system. However, up to date, it is unclear what causes the syndrome and how to diagnose and treat it. Although several treatments including medication and sympathetic nerve block are performed against CRPS, the therapeutic effect of the treatments is limited. The electroconvulsive thera-py (ECT), of which the mechanism is not clarified, is a treatment used for treatment-resistant depression. ECT is also reported to be effective against pain. Therefore, we performed the ECT for a 24-year-old female patient who has been diagnosed as CRPS. Her pain had not been much improved by medications and interventional procedures. At admission to a psychiatric ward for ECT, she com-plained of over 8 points of pain on visual analogue scale and the constrained movement around the painful part. Eight ECTs-three times a week-were performed for three weeks in hospital and then the ECT once a week was performed after her leaving the hospital. During the ECTs, pain had been reduced and the range of movement in the constrained parts had increased. Further systematic re-search is needed to confirm the effect of electroconvulsive therapy against CRPS.

• 생물정신의학
• /
• 제24권4호
• /
• pp.167-174
• /
• 2017

Based on advances in biotechnology and neuroscience, neuromodulation is poised to gain clinical importance as a treatment modality for psychiatric disorders. In addition to old-established electroconvulsive therapy (ECT), clinicians are expected to understand newer forms of neurostimulation, such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). Given the growing interest in non-invasive neuromodulation technologies, clinicians may seek sufficient information about neuromodulation to inform their clinical practice. A growing literature suggests that applications of non-invasive neuromodulation have evidence particularly for indications where treatments are currently insufficient, such as drug-resistant depression. However, positive neuromodulation studies require replication, and the precise interactions among stimulation, antidepressant medication, and psychotherapy are unknown. Further studies of long-term safety and the impact on the developing brain are needed. Non-invasive neuromodulatory devices could enable more individualized treatment. However, do-it-yourself (DIY) stimulation kits require a better understanding of the effects of more frequent patterns of stimulation and raise concerns about clinical supervision, regulation, and reimbursement. Wide spread enthusiasm for therapeutic potential of neuromodulation in clinical practice settings should be mitigated by the fact that there are still research gaps and challenges associated with non-invasive neuromodulatory devices.

• 대한미생물학회지
• /
• 제18권1호
• /
• pp.91-98
• /
• 1983

The effect of subcutanecus injection of Corynebacterium parvum($700{\mu}g$) on cellular and humoral immune responses when given at various time relative to sheep red blood cell(SRBC) sensitization were studied by the evaluation of Arthus, delayed-type hypersensitivity(DTH), rosette forming cell, hemagglutinin and hemolysin reactions. Arthus reactivity(3 hours) developed in control mice and test mice pretreated with C. parvum 8 days prior to intravenous sensitization with SRBC were similar. However, there was slight depression of reactivity when C. parvum was given subcutaneoutly(s.c.) 4 or 2 days prior to SRBC sensitization. Arthus reactivity was significantly depressed when C. parvum was given s.c. either at the same time as, or 2 days later than, antigen. DTH reaction was net depressed significantly when C. parvum was injected 8 or 2 days prior to SRBC sensitization or at the same time as antigen. In contrast DTH was significantly augmented when C. parvum given s.c. 4 days prier to SRBC sensitization. DTH was depressed when C. parvum was given s.c. 2 days after antigen. No significant change occurred in rosette forming percetages of spleen cell when C. parvum was given s.c. 8, 4 or 2 days before SRBC sensitization. In contrast, a significant reduction in percentages of rosette forming cell occurred when C. parvum was given s.c. either at the same time as, or 2 days later than, antigen. Serum hemaggulutinin and hemolysin titers were not significantly affected by subcutaneous injection of C. parvum regardless of time relative to SRBC sensitization. However, mercaptoethanol-resistant hemaggulutinin and hemolysin(IgG) titers were somewhat augmented when C. parvum was given 2 days after antigen. It is concluded from these results that depending on the time and route of inoculation, C. parvum can enhance or depress immune responses in mice, suggesting the time and route of C. parvum inoculation is an important point of concern about clinical use of C. parvum for the treatment of cancer.